Recent Activity
- May 18
A request from “someone with influence” to cease discussion of a sensitive topic prompts an editorial encouraging younger colleagues to stand up for what they believe.
- May 17
For the second time in the past 6 months, a cardiology mainstay drug has lost patent protection and gone generic. Today, the FDA announced that it had... - May 17A very large meta-analysis provides strong evidence that the relative reduction in vascular risk with statins is at least as great in low-risk patient...
- May 17Coffee drinking is inversely associated with mortality in a dose-dependent manner, according to a New England Journal of Medicine study. Mortality ris...
- May 17A genetics-based analysis finds that raising HDL will not necessarily lower risk for myocardial infarction. Reporting in the Lancet, researchers descr...
- May 17The antibiotic azithromycin — which may have proarrhythmic properties — is associated with increased risk for cardiovascular death, according to a ret...
- May 17
The St. Jude Riata ICD lead controversy took center stage at last week’s Heart Rhythm Scientific Sessions in Boston, as previously reported here. Nea... - May 16Reductions in air pollution during the Beijing Olympics were associated with decreases in certain biomarkers of inflammation and thrombosis in healthy...
- May 15Routine exercise echocardiography in asymptomatic patients after revascularization does not lead to better outcomes, according to a new study publishe...
- May 15The biggest drawback to drug-eluting stents has been the requirement for prolonged dual antiplatelet (DAPT) therapy following stent implantation to pr...
- May 15Interventional cardiology leader William O'Neill is leaving the University of Miami Miller School of Medicine to become the medical director of the ne...
- May 14A large study looking at real-world use of elective coronary artery bypass surgery (CABG) and stenting (PCI) in New York State finds that nearly two ...
- May 14
This week Richard discusses studies of glucose, insulin, and potassium for MI, elective PCI with and without surgical standby, and varenicline and CV risk.
- May 12Thursday morning at Heart Rhythm Scientific Sessions 2012, Suneet Mittal MD of Columbia University gave a detailed account of his group’s experience w...
- May 11
Harry Peled wonders whether intermediate-dose aspirin may simply be so effective that it obviates the need for a P2Y12-receptor antagonist.
- May 10
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted to recommend approval of lorcaserin (Lorqess, Arena). The vote was 18 in favor of approval, 4 against, and 1 abstention.
- May 10
The Heart Rhythm Society meeting kicked off in Boston this morning. Edward Schloss recounts the important opening session in which FDA-recalled St. Jude ICD leads Riata, Riata ST, and Durata were discussed.
- May 10Pfizer will no longer aggressively market Lipitor (atorvastatin), its former crown jewel and the most lucrative pharmaceutical product ever. At the sa...
- May 10Pfizer will no longer aggressively market Lipitor (atorvastatin), its former crown jewel and the most lucrative pharmaceutical product ever. At the sa...
- May 10
Harlan Krumholz shares his techniques for helping to heal the people whom a deceased patient leaves behind.
